Heart failure patients may soon get meds through a patch instead of an IV
NCT ID NCT04846816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a new patch-like device that delivers the heart failure drug furosemide under the skin. Twenty hospitalized heart failure patients received a single dose to see if it is safe and works well. The goal is to find a simpler way to give this medication without needles or IVs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- furosemide delivered via a patch infusor device
- What this could lead to
- If successful, this could offer a more convenient way to deliver furosemide for heart failure, potentially reducing hospital stays.
- What could go wrong
- This is a very early phase 1 trial with only 20 participants, so results may not apply to all patients. The device could fail or cause skin reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde
Glasgow, Glasgow, G51 4TF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?